The global gynaecological devices market size was estimated to be USD 9.56 billion in 2023 and is expected to reach at USD 25.5 billion by 2033 with a CAGR of 9.34% during the forecast period 2023-2033. Growing prevalence of gynaecological disorders such as endometriosis, polycystic ovary syndrome (PCOS), adenomyosis, & uterine fibroids, surge in number of surgical procedures such as female sterilization, ablation, endoscopy, & laparoscopy, increasing usage of disposable products, rising adoption of advanced and innovative technologies, growing advancement in the gynaecological devices, surge in development of advanced imaging devices such as 3D endoscopes, and rising launch of technologically advanced innovative devices are some of the key factors boosting the market growth.
Rising launch of technologically advanced innovative devices is predicted to boost the market growth during the forecast period. For instance, in March 2022, California's Endoluxe has introduced the Endoluxe eVS, a high-definition wireless endoscopic camera featuring TowerTech technology. This advanced device is specifically designed for gynecological, urological, ENT, orthopedic, and general surgical procedures.
By Product, Surgical devices was the highest revenue-grossing segment in the global Gynaecological Devices Market in 2022 owing to the rising usage of female contraceptives & endoscopic devices, growing surgical procedures, surge in need for surgical tools that are both easily autoclavable & extremely durable, increasing awareness regarding birth control devices & surgeries, rise in number of female sterilization procedures, increasing research & development activities in the field of endometrial balloon ablation, and growing new product launches. For instance, in November 2021, At the American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress, Hologic, Inc., a well-known player in the field of women's health, introduced its newest offering, the NovaSure V5 global endometrial ablation (GEA) device. Being the most extensively researched and reliable endometrial ablation procedure in the United States, this innovative NovaSure V5 device reflects Hologic's continuous dedication to improving the physician's journey and experience in the field. Additionally, Diagnostic imaging systems is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of intended & unintended pregnancies, increasing demand for advanced imaging systems, such as ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and plain radiography to determine harmful conditions in the pregnancy.
By End-user, Hospitals & clinics was the highest revenue-grossing segment in the global Gynaecological Devices Market in 2022 owing to the growing demand for gynaecological surgeries, rising adoption of advanced technologies in hospitals & clinics. For instance, in January 2022, Memic Innovative Surgery Ltd. made an announcement stating that the Hominis® Surgical System has been purchased by HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration, and The Women's Hospital at Jackson Memorial. The Hominis® Surgical System will be utilized by these medical centers to conduct single-site, laparoscopic-assisted transvaginal procedures through natural orifices for treating benign gynecological conditions, which also include benign hysterectomy. Additionally, Ambulatory Surgery Centers (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to the lower cost of these facilities in comparison to other healthcare facilities including hospitals & clinics and increasing adoption of technologically advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing awareness regarding the availability of diagnostic tests & treatments, increasing healthcare infrastructure, rising technological advancements, and surge in launch of new products. For instance, in June 2022, UroViu Corp has introduced the latest addition to their endoscopy platform, the Hystero-V, a single-use hysteroscope. This new device is fully compatible with UroViu's Always Ready endoscopy platform. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of gynaecological disorders, rising surgical procedures, increasing awareness regarding family planning & birth control, surge in government initiatives to control the growing population, and growing adoption of innovative technologies launched by major market players. For instance, in July 2021, Medtronic plc recently reported the successful utilization of their Hugo robotic-assisted surgery (RAS) system in gynecological (GYN) procedures for the first time. Earlier this month, Pacifica Salud Hospital in Panama City, Panama, conducted these six procedures.
Rising launch of technologically advanced innovative devices is predicted to boost the market growth during the forecast period. For instance, in March 2022, California's Endoluxe has introduced the Endoluxe eVS, a high-definition wireless endoscopic camera featuring TowerTech technology. This advanced device is specifically designed for gynecological, urological, ENT, orthopedic, and general surgical procedures.
By Product, Surgical devices was the highest revenue-grossing segment in the global Gynaecological Devices Market in 2022 owing to the rising usage of female contraceptives & endoscopic devices, growing surgical procedures, surge in need for surgical tools that are both easily autoclavable & extremely durable, increasing awareness regarding birth control devices & surgeries, rise in number of female sterilization procedures, increasing research & development activities in the field of endometrial balloon ablation, and growing new product launches. For instance, in November 2021, At the American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress, Hologic, Inc., a well-known player in the field of women's health, introduced its newest offering, the NovaSure V5 global endometrial ablation (GEA) device. Being the most extensively researched and reliable endometrial ablation procedure in the United States, this innovative NovaSure V5 device reflects Hologic's continuous dedication to improving the physician's journey and experience in the field. Additionally, Diagnostic imaging systems is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of intended & unintended pregnancies, increasing demand for advanced imaging systems, such as ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and plain radiography to determine harmful conditions in the pregnancy.
By End-user, Hospitals & clinics was the highest revenue-grossing segment in the global Gynaecological Devices Market in 2022 owing to the growing demand for gynaecological surgeries, rising adoption of advanced technologies in hospitals & clinics. For instance, in January 2022, Memic Innovative Surgery Ltd. made an announcement stating that the Hominis® Surgical System has been purchased by HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration, and The Women's Hospital at Jackson Memorial. The Hominis® Surgical System will be utilized by these medical centers to conduct single-site, laparoscopic-assisted transvaginal procedures through natural orifices for treating benign gynecological conditions, which also include benign hysterectomy. Additionally, Ambulatory Surgery Centers (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to the lower cost of these facilities in comparison to other healthcare facilities including hospitals & clinics and increasing adoption of technologically advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing awareness regarding the availability of diagnostic tests & treatments, increasing healthcare infrastructure, rising technological advancements, and surge in launch of new products. For instance, in June 2022, UroViu Corp has introduced the latest addition to their endoscopy platform, the Hystero-V, a single-use hysteroscope. This new device is fully compatible with UroViu's Always Ready endoscopy platform. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of gynaecological disorders, rising surgical procedures, increasing awareness regarding family planning & birth control, surge in government initiatives to control the growing population, and growing adoption of innovative technologies launched by major market players. For instance, in July 2021, Medtronic plc recently reported the successful utilization of their Hugo robotic-assisted surgery (RAS) system in gynecological (GYN) procedures for the first time. Earlier this month, Pacifica Salud Hospital in Panama City, Panama, conducted these six procedures.
Segmentation: Gynaecological Devices Market Report 2022 - 2033
Gynaecological Devices Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Diagnostic Imaging Systems
Handheld Instruments
- Biopsy Forceps
- Vaginal Speculum
- Trocars Market
- Curettes
- Tenaculum
- Others
Surgical Devices
- Fluid Management Systems
- Gynaecological Endoscopy Devices
- Laparoscope
- Colposcope
- Hysteroscope
Resectoscope
- Endoscopic imaging systems
- Balloon Ablation Devices
- Endometrial Ablation Devices
- Radiofrequency Ablation Devices
- Hydrothermal Ablation Devices
- Others
- Microwave
Laser
- Female Sterilization/Contraceptive Devices
- Intra Uterine Devices (IUD)
- Permanent Birth Control
- Intravaginal rings
- Subdermal Contraceptive Implants
Gynaecological Devices Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Hospitals & Clinics
- Ambulatory Surgery Centers (ASCs)
Gynaecological Devices Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Gynaecological Devices Market: Product Estimates & Trend Analysis
8. Gynaecological Devices Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Gynaecological Devices Market
11. Europe Global Gynaecological Devices Market
12. Asia Pacific Global Gynaecological Devices Market
13. Latin America Global Gynaecological Devices Market
14. MEA Global Gynaecological Devices Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Cook Medical
- Gynemed
- Hologic Inc.
- Gynex Corp.
- Bayer AG
- Stryker Corp.
- Cooper Surgical Inc.
- Medtronic plc
- Richard Wolf GmbH
- Olympus Corporation
- Boston Scientific Corp.
- Karl Storz GmbH & Co. KG
- Ethicon Inc. (Johnson & Johnson MedTech)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 9.56 Billion |
| Forecasted Market Value ( USD | $ 25.5 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
